nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—HRH3—attention deficit hyperactivity disorder	0.717	0.814	CbGaD
Donepezil—HTR2A—attention deficit hyperactivity disorder	0.164	0.186	CbGaD
Donepezil—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00595	0.182	CbGeAlD
Donepezil—HRH3—forebrain—attention deficit hyperactivity disorder	0.00381	0.116	CbGeAlD
Donepezil—Tetrabenazine—DRD2—attention deficit hyperactivity disorder	0.00333	0.664	CrCbGaD
Donepezil—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00316	0.0965	CbGeAlD
Donepezil—HRH3—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00287	0.0354	CbGpPWpGaD
Donepezil—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.00255	0.0314	CbGpPWpGaD
Donepezil—HRH3—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00247	0.0304	CbGpPWpGaD
Donepezil—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.00217	0.0267	CbGpPWpGaD
Donepezil—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.00215	0.0265	CbGpPWpGaD
Donepezil—HRH3—nervous system—attention deficit hyperactivity disorder	0.00207	0.0631	CbGeAlD
Donepezil—HRH3—central nervous system—attention deficit hyperactivity disorder	0.00199	0.0608	CbGeAlD
Donepezil—HRH3—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.00197	0.0243	CbGpPWpGaD
Donepezil—HRH3—cerebellum—attention deficit hyperactivity disorder	0.00195	0.0594	CbGeAlD
Donepezil—HRH3—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.00176	0.0217	CbGpPWpGaD
Donepezil—HRH3—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00174	0.0214	CbGpPWpGaD
Donepezil—Doxazosin—ADRA2A—attention deficit hyperactivity disorder	0.00168	0.336	CrCbGaD
Donepezil—HRH3—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00162	0.0199	CbGpPWpGaD
Donepezil—HRH3—brain—attention deficit hyperactivity disorder	0.00158	0.0482	CbGeAlD
Donepezil—HRH3—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00157	0.0193	CbGpPWpGaD
Donepezil—HRH3—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00154	0.019	CbGpPWpGaD
Donepezil—HTR2A—Serotonin receptors—HTR1B—attention deficit hyperactivity disorder	0.00154	0.019	CbGpPWpGaD
Donepezil—HRH3—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00152	0.0187	CbGpPWpGaD
Donepezil—HRH3—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00142	0.0175	CbGpPWpGaD
Donepezil—ACHE—midbrain—attention deficit hyperactivity disorder	0.00136	0.0415	CbGeAlD
Donepezil—ACHE—Biogenic Amine Synthesis—COMT—attention deficit hyperactivity disorder	0.00131	0.0162	CbGpPWpGaD
Donepezil—ACHE—Biogenic Amine Synthesis—MAOA—attention deficit hyperactivity disorder	0.0013	0.016	CbGpPWpGaD
Donepezil—ACHE—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00118	0.0145	CbGpPWpGaD
Donepezil—ACHE—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00116	0.0143	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00116	0.0142	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00113	0.0139	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00108	0.0133	CbGpPWpGaD
Donepezil—ACHE—cerebellum—attention deficit hyperactivity disorder	0.00105	0.0321	CbGeAlD
Donepezil—HRH3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000993	0.0122	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.000971	0.012	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.000951	0.0117	CbGpPWpGaD
Donepezil—ACHE—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.000944	0.0116	CbGpPWpGaD
Donepezil—SIGMAR1—midbrain—attention deficit hyperactivity disorder	0.000914	0.0279	CbGeAlD
Donepezil—ACHE—brain—attention deficit hyperactivity disorder	0.000856	0.0261	CbGeAlD
Donepezil—ACHE—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.000842	0.0104	CbGpPWpGaD
Donepezil—ACHE—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000769	0.00947	CbGpPWpGaD
Donepezil—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000757	0.0231	CbGeAlD
Donepezil—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000737	0.0225	CbGeAlD
Donepezil—HRH3—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000726	0.00894	CbGpPWpGaD
Donepezil—SIGMAR1—cerebellum—attention deficit hyperactivity disorder	0.000707	0.0216	CbGeAlD
Donepezil—HTR2A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.000686	0.00844	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000673	0.00829	CbGpPWpGaD
Donepezil—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000671	0.0205	CbGeAlD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00066	0.00812	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.000659	0.00812	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000655	0.00807	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.000638	0.00785	CbGpPWpGaD
Donepezil—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000623	0.019	CbGeAlD
Donepezil—HTR2A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.000617	0.0076	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.000607	0.00747	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000599	0.00738	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000577	0.00711	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000576	0.0071	CbGpPWpGaD
Donepezil—SIGMAR1—brain—attention deficit hyperactivity disorder	0.000574	0.0175	CbGeAlD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000565	0.00696	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000558	0.00688	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000536	0.0066	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000533	0.00656	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.000519	0.00639	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00051	0.00628	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000504	0.0062	CbGpPWpGaD
Donepezil—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000487	0.0148	CbGeAlD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000469	0.00578	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000439	0.00541	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000431	0.0053	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00043	0.0053	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000408	0.00503	CbGpPWpGaD
Donepezil—HTR2A—nervous system—attention deficit hyperactivity disorder	0.0004	0.0122	CbGeAlD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0004	0.00492	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000388	0.00478	CbGpPWpGaD
Donepezil—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000385	0.0117	CbGeAlD
Donepezil—HRH3—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000381	0.00469	CbGpPWpGaD
Donepezil—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000377	0.0115	CbGeAlD
Donepezil—HRH3—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000376	0.00464	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000372	0.00458	CbGpPWpGaD
Donepezil—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00037	0.0113	CbGeAlD
Donepezil—HRH3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00037	0.00456	CbGpPWpGaD
Donepezil—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000365	0.0111	CbGeAlD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00036	0.00443	CbGpPWpGaD
Donepezil—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000357	0.0109	CbGeAlD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000354	0.00436	CbGpPWpGaD
Donepezil—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000351	0.0107	CbGeAlD
Donepezil—HRH3—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000351	0.00432	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000349	0.0043	CbGpPWpGaD
Donepezil—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000343	0.0105	CbGeAlD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000342	0.00422	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000336	0.00414	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000325	0.00401	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000318	0.00392	CbGpPWpGaD
Donepezil—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000315	0.00388	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000308	0.0038	CbGpPWpGaD
Donepezil—HTR2A—brain—attention deficit hyperactivity disorder	0.000306	0.00933	CbGeAlD
Donepezil—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000304	0.00375	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000303	0.00373	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000299	0.00369	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000279	0.00343	CbGpPWpGaD
Donepezil—CYP2D6—brain—attention deficit hyperactivity disorder	0.000279	0.0085	CbGeAlD
Donepezil—HTR2A—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.000274	0.00338	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000273	0.00336	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.000266	0.00328	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000261	0.00321	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000248	0.00306	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000243	0.003	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000242	0.00299	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000235	0.00289	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000234	0.00289	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000231	0.00284	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00023	0.00283	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000228	0.00281	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000228	0.00281	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000225	0.00278	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000223	0.00275	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000221	0.00272	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000218	0.00269	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000218	0.00268	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000217	0.00267	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000212	0.00262	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000209	0.00257	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000199	0.00245	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000198	0.00244	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000195	0.00241	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000194	0.00239	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000191	0.00235	CbGpPWpGaD
Donepezil—ACHE—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000188	0.00232	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000187	0.0023	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000184	0.00227	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000184	0.00227	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00018	0.00221	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000167	0.00206	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000165	0.00203	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000164	0.00202	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000164	0.00202	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000155	0.00191	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000151	0.00186	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000149	0.00183	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000149	0.00183	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000147	0.00181	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000145	0.00179	CbGpPWpGaD
Donepezil—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000143	0.00176	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000143	0.00175	CbGpPWpGaD
Donepezil—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000142	0.00174	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000138	0.00171	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000137	0.00169	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000134	0.00165	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000134	0.00165	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000133	0.00164	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000133	0.00163	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000132	0.00163	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00013	0.00161	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00013	0.00161	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00013	0.0016	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000129	0.00159	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000128	0.00158	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000127	0.00156	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000126	0.00155	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000124	0.00153	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000123	0.00152	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000123	0.00151	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000121	0.00148	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00012	0.00148	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000119	0.00147	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000118	0.00146	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000117	0.00144	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000117	0.00144	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000116	0.00142	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000113	0.0014	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000111	0.00137	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000109	0.00134	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000108	0.00133	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000105	0.0013	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000102	0.00126	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0001	0.00124	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.91e-05	0.00122	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.88e-05	0.00122	CbGpPWpGaD
Donepezil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.34e-05	0.00115	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	9.23e-05	0.00114	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.63e-05	0.00106	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.41e-05	0.00104	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.22e-05	0.00101	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.05e-05	0.000992	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.03e-05	0.000988	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.91e-05	0.000974	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.77e-05	0.000957	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.65e-05	0.000941	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.64e-05	0.000941	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.63e-05	0.00094	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.62e-05	0.000939	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.59e-05	0.000935	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.58e-05	0.000933	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.55e-05	0.000929	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.54e-05	0.000929	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.53e-05	0.000927	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.48e-05	0.000921	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.46e-05	0.000919	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	7.35e-05	0.000905	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.35e-05	0.000905	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.31e-05	0.000901	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.12e-05	0.000877	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.03e-05	0.000866	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7e-05	0.000862	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.91e-05	0.000851	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.57e-05	0.00081	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.44e-05	0.000793	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.98e-05	0.000736	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.58e-05	0.000687	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.26e-05	0.000648	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TPH2—attention deficit hyperactivity disorder	5.26e-05	0.000648	CbGpPWpGaD
Donepezil—ACHE—Metabolism—DPYD—attention deficit hyperactivity disorder	5.18e-05	0.000637	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.13e-05	0.000632	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.07e-05	0.000624	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	5e-05	0.000616	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.96e-05	0.000611	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.93e-05	0.000607	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.88e-05	0.000601	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.81e-05	0.000593	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.54e-05	0.000559	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.51e-05	0.000555	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.43e-05	0.000546	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.41e-05	0.000543	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.39e-05	0.000541	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.32e-05	0.000532	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.32e-05	0.000532	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.26e-05	0.000525	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.24e-05	0.000522	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.21e-05	0.000518	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.12e-05	0.000507	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4e-05	0.000493	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.99e-05	0.000491	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.97e-05	0.000489	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.92e-05	0.000483	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.87e-05	0.000477	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.61e-05	0.000444	CbGpPWpGaD
Donepezil—ACHE—Metabolism—COMT—attention deficit hyperactivity disorder	3.19e-05	0.000393	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MAOA—attention deficit hyperactivity disorder	3.17e-05	0.00039	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.13e-05	0.000385	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.1e-05	0.000382	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.07e-05	0.000378	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.99e-05	0.000369	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.62e-05	0.000322	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.43e-05	0.0003	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.39e-05	0.000294	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.36e-05	0.00029	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.32e-05	0.000285	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.29e-05	0.000282	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.16e-05	0.000266	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.16e-05	0.000266	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	2.14e-05	0.000263	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.14e-05	0.000263	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.13e-05	0.000262	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.12e-05	0.000261	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	2.1e-05	0.000259	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.04e-05	0.000252	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.97e-05	0.000243	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.96e-05	0.000241	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.73e-05	0.000212	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.71e-05	0.000211	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.64e-05	0.000202	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.63e-05	0.0002	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.41e-05	0.000174	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.41e-05	0.000174	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.39e-05	0.000171	CbGpPWpGaD
Donepezil—ACHE—Metabolism—EP300—attention deficit hyperactivity disorder	1.37e-05	0.000168	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.31e-05	0.000161	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.3e-05	0.00016	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.3e-05	0.00016	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.29e-05	0.000159	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.29e-05	0.000158	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.25e-05	0.000154	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.13e-05	0.000139	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.07e-05	0.000132	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.55e-06	0.000105	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.49e-06	0.000105	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.91e-06	9.74e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.61e-06	6.9e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	5.56e-06	6.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.67e-06	4.51e-05	CbGpPWpGaD
